Urine test strips market seen reaching $3.2B by 2030

The urine test strips market is projected to climb from $2.1 billion in 2025 to $3.21 billion by 2030, fueled by rising diabetes cases, kidney disease screening and demand for home testing. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Urine test strips are a low-cost tool for monitoring diabetes, kidney disease and urinary tract infections. - Rising demand for faster, at-home and multi-parameter testing is reshaping a basic diagnostic category. - Growth in this market signals broader adoption of digital and automated diagnostics in everyday care.

What happened: - The Business Research Company projected the urine test strips market will rise from $2.1 billion in 2025 to $2.29 billion in 2026. - The report said the market will reach $3.21 billion by 2030, implying an 8.7% compound annual growth rate. - The report is titled Urine Test Strips Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The company published the market update from London on Sept. 2, 2026. - The report defines urine test strips, also called urinalysis test strips or dipsticks, as diagnostic devices that detect and measure substances in urine through chemically treated pads that change color.

The details: - The report linked recent growth to limited availability of multi-parameter urine test strips, heavy reliance on visual testing, rising diabetes and kidney disease cases, expansion in diagnostic laboratories and greater awareness of urinary health. - The forecast period is expected to be driven by better automated test strip analyzers, more home-based diagnostic options, integration with digital health platforms, broader diabetes and kidney screening programs and wider use of multi-analyte testing. - Key trends expected in the market include more home urine testing, greater use of automated analyzers, expansion in urinary tract infection diagnostics and more precise rapid result interpretation. - The report said diabetes is a major growth driver because urine test strips can detect glucose or ketone levels that signal high blood sugar or complications. - The Institute for Health Metrics and Evaluation reported in June 2023 that more than 500 million people globally were living with diabetes, with that figure projected to surpass 1.3 billion by 2050. - Additional growth drivers include rising kidney disorders, more urinary tract infections, higher healthcare infrastructure spending and stronger awareness of early diagnosis and urinary monitoring. - The report also pointed to innovation in multi-parameter strips and integration with digital healthcare technologies as demand drivers. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample report is available as the urine test strips market sample. - The full report is available as the urine test strips market report.

Between the lines: - The market outlook suggests routine diagnostics are moving away from manual reading and toward connected, automated interpretation. - Diabetes screening remains the clearest demand anchor, but home use and digital integration appear to be widening the addressable market. - Regional growth is shifting toward Asia-Pacific, which may reflect faster healthcare expansion and rising chronic disease screening needs.

What's next: - The report expects automation, home testing and digital health integration to support continued growth through 2030. - Wider screening for diabetes and kidney disease could increase test strip use across clinics, labs and households. - The company listed expanded 2026 report features including TAM analysis, company scoring matrices, forecasting dashboards, market hotspots infographics and updated graphics and tables.